Current News Saturday, July 4, 2009 Biotech Pharma
BioCis Pharma Reports Positive Phase IIa Clinical Results in Atopic Dermatitis
TURKU, Finland, July 3 /PRNewswire/ -- BioCis Pharma Ltd., a privately
held drug development... more
Bay Area Youth to Represent ALS Patients at Giants' and Angels' Baseball Games on July 4th
Corey Reich, 23, ALS Ambassador for the World's Largest ALS Research Center, will Participate in Events and Meet with Patients and Advocates
SAN FRANCISCO, July 3 /PRNewswire-USNewswire/ -- Tomorrow, Corey Reich, an ALS patient from... more
UNT Health Science Center's Groundbreaking Research Applied to Protecting Brain After Traumatic Injury
Simpkins' estrogen research could save lives of trauma victims
FORT WORTH, Texas, July 3 /PRNewswire-USNewswire/ -- In groundbreaking research, scientists at... more
Multi-Cultural
The 2009 Essence Music Festival Presented By Coca-Cola:
THE ULTIMATE PARTY WEEKEND TO FEATURE HEADLINE PERFORMANCES BY BEYONCE, MAXWELL, ANITA BAKER, LIONEL RICHIE, AL GREEN, JOHN LEGEND, NE-YO, SALT-N-PEPA, ROBIN THICKE, CHARLIE WILSON, JAZMINE SULLIVAN, MAZE FEATURING FRANKIE BEVERLY, TEENA MARIE AND EN VOGUE
NEW YORK, July 3 /PRNewswire/ --
SATELLITE FEEDS:
UPLINK TIMES (EASTERN... more
AWS Spectrum Critical for the Growth of Mobile Broadband Across the Americas According to GSMA-Backed Research
New research estimates 177.8 million AWS subscribers by end of 2013 across the US, Canada and Latin America
LONDON, July 2 /PRNewswire/ -- The licensing of the Advanced Wireless Services (AWS) band* will... more
Hola Mexico Film Festival USA '09 and Cinelatino Announce Audience Choice Award Winner
Cinelatino 2009 Audience Choice Award is Festival's Only Award
NEW YORK, July 2 /PRNewswire/ -- The multi-city Hola Mexico Film Festival USA '09 and Cinelatino,... more
FDA
FDA Approves Multaq(R) for Patients with Atrial Fibrillation or Atrial Flutter
- Multaq(R) approved to reduce the risk of cardiovascular hospitalization in patients with atrial fibrillation or atrial flutter -- U.S. commercial launch planned for the summer of 2009 -
PARIS, July 2 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) announced... more
Nephros Receives 510k Approval for Dual Stage Ultrafilters
RIVER EDGE, N.J., July 2 /PRNewswire-FirstCall/ -- Nephros, Inc. (OTC Bulletin Board: NEPH), a... more
Study Showed VYVANSE(R) (lisdexamfetamine dimesylate) CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD in an Adult Simulated Workplace Environment
VYVANSE is the first stimulant to establish duration of efficacy from two hours up to 14 hours... more
|
